They found that dopamine at 100 µg/min caused increased natriuresis in patients with congestive heart failure. Still, more than 40 years since that report, low-dose dopamine for this indication ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).